Sponsored
In this video, Dr Graff talks about how the treatment landscape for CLL has evolved in recent years, especially with the introduction of acalabrutinib.
Sponsored
In this video, Dr Goy discusses recent innovations in the treatment of patients with MCL.
Anees Chagpar, MD, MSc, MPH, MA, MBA, FACS, FRCS(C), Yale School of Medicine, discusses her presentation of, "Neoadjuvant Chemotherapy for a 1.5 cm Clinically Node-Negative Breast Cancer," presented…
Anees Chagpar, MD, MSc, MPH, MA, MBA, FACS, FRCS(C), highlights notable research and presentations from the 2021 Miami Breast Cancer Conference.
Kelly Hunt, MD, MD Anderson Cancer Center, Houston, Texas, discusses findings following, "Neoadjuvant Endocrine Therapy: Optimal Strategies and Impact on Surgical Outcomes", presented at the 2021…
Fred Saad, MD, discusses the findings of ACIS, a phase 3 clinical trial of apalutamide and abiraterone acetate plus prednisone vs abiraterone alone for chemotherapy-naive CRPC.
Felix Fang, MD, University of California at San Francisco, Benioff Initiative for Prostate Cancer Research, discusses identifying molecular determinants of response to apalutamide in nonmetastatic…
Sponsored
In this video, Christina Wu, MD, discusses HER2 in patients with metastatic CRC.
Sponsored
In part 3 of this video series, Marwan Fakih, MD, discusses how oncologists can make the biomarker testing process understandable for patients with metastatic CRC.
Sponsored
In part 2 of this video series, Marwan Fakih, MD, discusses testing strategies for detecting mutations in patients with metastatic CRC.
Stay in the know.
OncNet Newsletter